A Soluble Sulfogalactosyl Ceramide Mimic Promotes ΔF508 CFTR Escape from Endoplasmic Reticulum Associated Degradation

Chemistry and Biology

Volumn 16, Issue 4, 2009, Pages 461-470

  Park, Hyun Joo ^a   Mylvaganum, Murugesapillai ^a   McPherson, Anne ^a   Fewell, Sheara W ^b   Brodsky, Jeffrey L ^b   Lingwood, Clifford A ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

CELLBIO; CHEMBIO

Indexed keywords

ADAMANTANE; ADENOSINE TRIPHOSPHATE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508; GALACTOSYLCERAMIDE; GLYCOSPHINGOLIPID; HEAT SHOCK COGNATE PROTEIN 70; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; CHEMISTRY; DRUG ANTAGONISM; ENDOPLASMIC RETICULUM; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HAMSTER; METABOLISM; MOUSE; PROTEIN BINDING; TUMOR CELL LINE;

ADAMANTANE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; CRICETINAE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC RETICULUM; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; GLYCOSPHINGOLIPIDS; HSC70 HEAT-SHOCK PROTEINS; MICE; PROTEIN BINDING; TRANSFECTION;

CRICETINAE; MUS;

EID: 64749115962     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.02.014     Document Type: Article

References (62)

1. Amaral M.D. Processing of CFTR: traversing the cellular maze-how much CFTR needs to go through to avoid cystic fibrosis?. Pediatr. Pulmonol. 39 (2005) 479-491
2. Arndt V., Daniel C., Nastainczyk W., Alberti S., and Hohfeld J. BAG-2 acts as an inhibitor of the chaperone-associated ubiquitin ligase CHIP. Mol. Biol. Cell 16 (2005) 5891-5900
3. Brodsky J.L. Chaperoning the maturation of the cystic fibrosis transmembrane conductance regulator. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L39-L42
4. Brodsky J.L. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem. J. 404 (2007) 353-363
5. Brown C.R., Hong-Brown L.Q., Biwersi J., Verkman A.S., and Welch W.J. Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1 (1996) 117-125
6. Choudhury A., Dominguez M., Puri V., Sharma D.K., Narita K., Wheatley C.L., Marks D.L., and Pagano R.E. Rab proteins mediate Golgi transport of caveola-internalized glycosphingolipids and correct lipid trafficking in Niemann-Pick C cells. J. Clin. Invest. 109 (2002) 1541-1550
7. Denning G.M., Anderson M.P., Amara J.F., Marshall J., Smith A.E., and Welsh M.J. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358 (1992) 761-764
8. Devuyst O., Burrow C.R., Schwiebert E.M., Guggino W.B., and Wilson P.D. Developmental regulation of CFTR expression during human nephrogenesis. Am. J. Physiol. 271 (1996) F723-F735
9. Emam A., Yu A., Park H.-J., Mahfoud R., Kus J., Burrows L., and Lingwood C. Laboratory and clinical Pseudomonas aeruginosa strains do not bind glycosphingolipids in vitro or during type IV pili-mediated initial host cell attachment. Microbiology 152 (2006) 2789-2799
10. Farinha C.M., and Amaral M.D. Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin. Mol. Cell. Biol. 25 (2005) 5242-5252
11. Farinha C.M., Nogueira P., Mendes F., Penque D., and Amaral M.D. The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70. Biochem. J. 366 (2002) 797-806
12. Farmen S.L., Karp P.H., Ng P., Palmer D.J., Koehler D.R., Hu J., Beaudet A.L., Zabner J., and Welsh M.J. Gene transfer of CFTR to airway epithelia: low levels of expression are sufficient to correct Cl- transport and overexpression can generate basolateral CFTR. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L1123-L1130
13. Fewell S.W., Day B.W., and Brodsky J.L. Identification of an inhibitor of hsc70-mediated protein translocation and ATP hydrolysis. J. Biol. Chem. 276 (2001) 910-914
14. Fewell S.W., Smith C.M., Lyon M.A., Dumitrescu T.P., Wipf P., Day B.W., and Brodsky J.L. Small molecule modulators of endogenous and co-chaperone-stimulated Hsp70 ATPase activity. J. Biol. Chem. 279 (2004) 51131-51140
15. Fredman P., Mattsson L., Andersson K., Davidsson P., Ishizuka I., Jeansson S., Mansson J.-E., and Svennerholm L. Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem. J. 251 (1988) 17-22
16. Gentzsch M., Choudhury A., Chang X.B., Pagano R.E., and Riordan J.R. Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking. J. Cell. Sci. 120 (2007) 447-455
17. Gondre-Lewis M.C., McGlynn R., and Walkley S.U. Cholesterol accumulation in NPC1-deficient neurons is ganglioside dependent. Curr. Biol. 13 (2003) 1324-1329
18. Hartmann E., Lingwood C., and Reidl J. Heat inducible surface stress protein (Hsp70) mediates sulfatide recognition of the respiratory pathogen Haemophilus influenzae. Infect. Immun. 69 (2001) 3438-3441
19. Hohfeld J., Cyr D.M., and Patterson C. From the cradle to the grave: molecular chaperones that may choose between folding and degradation. EMBO Rep. 2 (2001) 885-890
20. Huesca M., Borgia S., Hoffman P., and Lingwood C.A. Acidic pH changes receptor binding of Helicobacter pylori: a binary adhesion model in which surface heat-shock (stress) proteins mediate sulfatide recognition in gastric colonization. Infect. Immun. 64 (1996) 2643-2648
21. Jiang C., Fang S., Xiao Y., O'Connor S., Nadler S., Lee D., Jefferson D., Kaplan J., Smith A., and Cheng S. Partial restoration of cAMP-stimulated CFTR chloride channel activity in DeltaF508 cells by deoxyspergualin. Am. J. Physiol. 275 (1998) C171-C178
22. Lee L., Abe A., and Shayman J.A. Improved inhibitors of glucosylceramide synthase. J. Biol. Chem. 274 (1999) 14662-14669
23. Lingwood C., Hay G., and Schachter H. Tissue distribution of sulfolipids in the rat. Restricted location of sulfogalactosylacylalkylglycerol. Can. J. Biochem. 59 (1981) 556-563
24. Lingwood C.A., Quinn P.A., Wilansky S., Nutikka A., Ruhnke H., and Miller R.B. Common sulfoglycolipid receptor for mycoplasma involved in infertility. Biol. Reprod. 43 (1990) 694-697
25. Loffing J., Moyer B.D., Reynolds D., and Stanton B.A. PBA increases CFTR expression but at high doses inhibits Cl(-) secretion in Calu-3 airway epithelial cells. Am. J. Physiol. 277 (1999) L700-L708
26. Lukacs G., Mohamed A., Kartner N., Chang X., and Riordan J. Conformational maturation of CFTR but not it's mutant counterpart (Δ508) occurs in the endoplasmic reticulum and requires ATP. EMBO J. 13 (1994) 6076-6086
27. Mamelak D., and Lingwood C. The ATPase domain of Hsp70 possesses a unique binding specificity for 3′sulfogalactolipids. J. Biol. Chem. 276 (2001) 449-456
28. Mamelak D., Mylvaganam M., Whetstone H., Hartmann E., Lennarz W., Wyrick P., Raulston J., Han H., Hoffman P., and Lingwood C. Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by prokaryotic and eukaryotic hsp70 family members. Biochemistry 40 (2001) 3572-3582
29. Mamelak D., Mylvaganam M., Tanahashi E., Ito H., Ishida H., Kiso M., and Lingwood C. The aglycone of sulfogalactolipids can alter the sulfate ester substitution position required for hsc70 recognition. Carbohydr. Res. 335 (2001) 91-100
30. McClellan A.J., and Brodsky J.L. Mutation of the ATP-binding pocket of SSA1 indicates that a functional interaction between Ssa1p and Ydj1p is required for post-translational translocation into the yeast endoplasmic reticulum. Genetics 156 (2000) 501-512
31. McClellan A.J., Endres J.B., Vogel J.P., Palazzi D., Rose M.D., and Brodsky J.L. Specific molecular chaperone interactions and an ATP-dependent conformational change are required during posttranslational protein translocation into the yeast ER. Mol. Biol. Cell 9 (1998) 3533-3545
32. Meacham G.C., Patterson P., Zhang W., Younger J.M., and Cyr D.M. The hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat. Cell Biol. 3 (2001) 100-105
33. Mohamed A., Ferguson D., Seibert F.S., Cai H.M., Kartner N., Grinstein S., Riordan J.R., and Lukacs G.L. Functional expression and apical localization of the cystic fibrosis transmembrane conductance regulator in MDCK I cells. Biochem. J. 322 (1997) 259-265
34. Nadler S.G., Tepper M.A., Schacter B., and Mazzucco C.E. Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins. Science 258 (1992) 484-486
35. Nguyen T.D., Kim U.S., and Perrine S.P. Novel short chain fatty acids restore chloride secretion in cystic fibrosis. Biochem. Biophys. Res. Commun. 342 (2006) 245-252
36. Nutikka A., Binnington-Boyd B., and Lingwood C. Methods for the identification of host receptors for Shiga toxin. In: Philpot D., and Ebel F. (Eds). Methods in Molecular Medicine, Volume 73, E.coli Shiga Toxin Methods and Protocols (2003), Humana Press, Totowa, NY 197-208
37. Pagano R.E. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358 (2003) 885-891
38. Pagano R.E., Puri V., Dominguez M., and Marks D. Membrane traffic in sphingolipid storage diseases. Traffic 1 (2000) 807-815
39. Pasyk E.A., and Foskett J.K. Cystic fibrosis transmembrane conductance regulator-associated ATP and adenosine 3′-phosphate 5′-phosphosulfate channels in endoplasmic reticulum and plasma membranes. J. Biol. Chem. 272 (1997) 7746-7751
40. Poschet J.F., Boucher J.C., Tatterson L., Skidmore J., Van Dyke R.W., and Deretic V. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung. Proc. Natl. Acad. Sci. USA 98 (2001) 13972-13977
41. Poschet J., Perkett E., and Deretic V. Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment. Trends Mol. Med. 8 (2002) 512-519
42. Riordan J.R., Rommens J.M., Kerem B., Alon N., Rozmahel R., Grzelczak Z., Zielenski J., Lok S., Plavsic N., Chou J.L., et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245 (1989) 1066-1073
43. Rubenstein R.C., and Lyons B.M. Sodium 4-phenylbutyrate downregulates Hsc70 expression by facilitating mRNA degradation. Am. J. Physiol. Lung Cell. Mol. Physiol. 281 (2001) L43-L51
44. Rubenstein R.C., and Zeitlin P.L. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function. Am. J. Respir. Crit. Care Med. 157 (1998) 484-490
45. Rubenstein R.C., and Zeitlin P.L. Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR. Am. J. Physiol. Cell Physiol. 278 (2000) C259-C267
46. Rubenstein R.C., Egan M.E., and Zeitlin P.L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100 (1997) 2457-2465
47. Sakac D., Zachos M., and Lingwood C.A. Purification of the testicular galactolipid 3′ phosphoadenosine 5′ phosphosulfate sulfotransferase. J. Biol. Chem. 267 (1992) 1655-1659
48. Sharma M., Benharouga M., Hu W., and Lukacs G.L. Conformational and temperature-sensitive stability defects of the delta F508 cystic fibrosis transmembrane conductance regulator in post-endoplasmic reticulum compartments. J. Biol. Chem. 276 (2001) 8942-8950
49. Sharma M., Pampinella F., Nemes C., Benharouga M., So J., Du K., Bache K.G., Papsin B., Zerangue N., Stenmark H., and Lukacs G.L. Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J. Cell Biol. 164 (2004) 923-933
50. Singh O.V., Vij N., Mogayzel Jr. P.J., Jozwik C., Pollard H.B., and Zeitlin P.L. Pharmacoproteomics of 4-phenylbutyrate-treated IB3-1 cystic fibrosis bronchial epithelial cells. J. Proteome Res. 5 (2006) 562-571
51. Soriano J.M., Gonzalez L., and Catala A.I. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Prog. Lipid Res. 44 (2005) 345-356
52. Srinivasan A., McClellan A.J., Vartikar J., Marks I., Cantalupo P., Li Y., Whyte P., Rundell K., Brodsky J.L., and Pipas J.M. The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol. Cell. Biol. 17 (1997) 4761-4773
53. Teichgraber V., Ulrich M., Endlich N., Riethmuller J., Wilker B., De Oliveira-Munding C.C., van Heeckeren A.M., Barr M.L., von Kurthy G., Schmid K.W., et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat. Med. 14 (2008) 382-391
54. Trick D., Decker J., Groene H.J., Schulze M., and Wiegandt H. Regional expression of sulfatides in rat kidney: immunohistochemical staining by use of monospecific polyclonal antibodies. Histochem. Cell Biol. 111 (1999) 143-151
55. Ward C.L., Omura S., and Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83 (1995) 121-127
56. Whetstone D., and Lingwood C. 3′Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro. Biochemistry 42 (2003) 1611-1617
57. White N.M., Corey D.A., and Kelley T.J. Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. Am. J. Respir. Cell Mol. Biol. 31 (2004) 538-543
58. White N.M., Jiang D., Burgess J.D., Bederman I.R., Previs S.F., and Kelley T.J. Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 292 (2007) L476-L486
59. Wright J.M., Zeitlin P.L., Cebotaru L., Guggino S.E., and Guggino W.B. Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol. Genomics 16 (2004) 204-211
60. Xu Y., Liu C., Clark J.C., and Whitsett J.A. Functional genomic responses to cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR(delta508) in the lung. J. Biol. Chem. 281 (2006) 11279-11291
61. Zeitlin P.L., Diener-West M., Rubenstein R.C., Boyle M.P., Lee C.K., and Brass-Ernst L. Evidence of CFTR function in cystic fibrosis after systemic administration of 4-phenylbutyrate. Mol. Ther. 6 (2002) 119-126
62. Zhang Y., Nijbroek G., Sullivan M.L., McCracken A.A., Watkins S.C., Michaelis S., and Brodsky J.L. Hsp70 molecular chaperone facilitates endoplasmic reticulum-associated protein degradation of cystic fibrosis transmembrane conductance regulator in yeast. Mol. Biol. Cell 12 (2001) 1303-1314